The MHRA has cut the recommended use of xylometazoline and oxymetazoline nasal sprays to five days over rebound congestion risks.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/mhra-cuts-nasal-decongestant-spray-limit-five-days-2026a1000dzj?src=rss
Author :
Publish date : 2026-05-01 16:56:00
Copyright for syndicated content belongs to the linked Source.
